129 related articles for article (PubMed ID: 37563868)
1. Centella triterpenes cream as a potential drug for the treatment of hypertrophic scar through inhibiting the phosphorylation of STAT3: A network pharmacology analysis and in vitro experiments.
Tan M; Wu D; Zhou Y; Duan B
J Cosmet Dermatol; 2023 Dec; 22(12):3511-3519. PubMed ID: 37563868
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of Semen Persicae-Flos Carthami in treating hypertrophic scar: A study based on network pharmacological analysis and in vitro experiments.
Li X; Huang Z; Chao H; Lin X
Chem Biol Drug Des; 2024 Jan; 103(1):e14412. PubMed ID: 38056934
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
[TBL] [Abstract][Full Text] [Related]
4. Anti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K/AKT and STAT3 signaling pathways in scar-forming fibroblasts.
Shi J; Li J; Guan H; Cai W; Bai X; Fang X; Hu X; Wang Y; Wang H; Zheng Z; Su L; Hu D; Zhu X
PLoS One; 2014; 9(5):e98228. PubMed ID: 24878845
[TBL] [Abstract][Full Text] [Related]
5. Ellagic acid inhibits the formation of hypertrophic scars by suppressing TGF-β/Smad signaling pathway activity.
Zhao ZJ; Wu DJ; Lv DL; Zhang BD; Chen L; Sun YQ
Chem Biol Drug Des; 2023 Oct; 102(4):773-781. PubMed ID: 37386691
[TBL] [Abstract][Full Text] [Related]
6. ALA-PDT promotes the death and contractile capacity of hypertrophic scar fibroblasts through inhibiting the TGF-β1/Smad2/3/4 signaling pathway.
Qu Z; Chen Y; Du K; Qiao J; Chen L; Chen J; Wei L
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103915. PubMed ID: 38128289
[TBL] [Abstract][Full Text] [Related]
7. Umbilical cord-derived mesenchymal stem cells exert anti-fibrotic action on hypertrophic scar-derived fibroblasts in co-culture by inhibiting the activation of the TGF β1/Smad3 pathway.
Meng X; Gao X; Chen X; Yu J
Exp Ther Med; 2021 Mar; 21(3):210. PubMed ID: 33574910
[TBL] [Abstract][Full Text] [Related]
8. Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.
Li Y; Yu Z; Zhao D; Han D
Life Sci; 2021 Jul; 277():119483. PubMed ID: 33862115
[TBL] [Abstract][Full Text] [Related]
9. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
10. [Expression of endosialin in human hypertrophic scars and its regulation on fibroblast phenotype].
Zhang QY; Zhang LX; Han DH; Jiao XC; Zheng Z; Guo K; Yang YS
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Dec; 39(12):1168-1174. PubMed ID: 38129304
[No Abstract] [Full Text] [Related]
11. TMT quantitative proteomics and network pharmacology reveal the mechanism by which asiaticoside regulates the JAK2/STAT3 signaling pathway to inhibit peritoneal fibrosis.
Sun J; Tang L; Shan Y; Yu M; Sheng L; Huang L; Cao H; Dai H; Wang F; Zhao J; Sheng M
J Ethnopharmacol; 2023 Jun; 309():116343. PubMed ID: 36906159
[TBL] [Abstract][Full Text] [Related]
12. Smad interacting protein 1 influences transforming growth factor-β
Fang X; Hu X; Zheng Z; Tao K; Wang H; Guan H; Shi J; Ji P; Cai W; Bai X; Zhu X; Han J; Liu J; Hu D
J Mol Histol; 2019 Dec; 50(6):503-514. PubMed ID: 31595443
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of lysyl oxidase like 1 inhibits the proliferation and pro-fibrotic effects of transforming growth factor-β1-induced hypertrophic scar fibroblasts.
Ying M; Chen Y; Yuan B
Can J Physiol Pharmacol; 2021 Dec; 99(12):1272-1279. PubMed ID: 34283938
[TBL] [Abstract][Full Text] [Related]
14. Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts.
Fan C; Dong Y; Xie Y; Su Y; Zhang X; Leavesley D; Upton Z
Int J Mol Med; 2015 Oct; 36(4):985-91. PubMed ID: 26239419
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-4 critically controls transforming growth factor β1 induced hypertrophic scar formation.
Qian W; Li N; Cao Q; Fan J
J Cell Physiol; 2018 Jan; 234(1):731-739. PubMed ID: 30132849
[TBL] [Abstract][Full Text] [Related]
16. LY2109761 reduces TGF-β1-induced collagen production and contraction in hypertrophic scar fibroblasts.
Wei G; Xu Q; Liu L; Zhang H; Tan X; Zhang C; Han C; Guo Y; Han G; Zhang C
Arch Dermatol Res; 2018 Oct; 310(8):615-623. PubMed ID: 30046895
[TBL] [Abstract][Full Text] [Related]
17. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
18. The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar.
Ray S; Ju X; Sun H; Finnerty CC; Herndon DN; Brasier AR
J Invest Dermatol; 2013 May; 133(5):1212-20. PubMed ID: 23303450
[TBL] [Abstract][Full Text] [Related]
19. Curcumin alleviates hypertrophic scarring by inhibiting fibroblast activation and regulating tissue inflammation.
Fei H; Qian Y; Pan T; Wei Y; Hu Y
J Cosmet Dermatol; 2024 Jan; 23(1):227-235. PubMed ID: 37400988
[TBL] [Abstract][Full Text] [Related]
20. Panax Notoginseng Saponins suppresses TRPM7 via the PI3K/AKT pathway to inhibit hypertrophic scar formation in vitro.
Zhi Y; Wang H; Huang B; Yan G; Yan LZ; Zhang W; Zhang J
Burns; 2021 Jun; 47(4):894-905. PubMed ID: 33143990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
